Company filings profile · CIK 0001938569
Palomino Laboratories Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Palomino Laboratories Inc. (PALX): 7 filings in the last 90 days vs 7 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 15, 2026. Source-linked, daily-refreshed.
Material 8-K events — Palomino Laboratories Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Aug 5, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 16, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 24, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 9, 2026 | Other Events | ↗ |
| Oct 30, 2025 | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Oct 6, 2025 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Item 3.03; Change in Control; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.05; Item 5.06; Financial Statements and Exhibits | ↗ |
Watch Palomino Laboratories Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 14, 2026 | 8-K/A | Financial Statements and Exhibits | ↗ |
| Oct 8, 2026 | DEF 14A | DEF 14A | ↗ |
| Sep 28, 2026 | PRE 14A | PRE 14A | ↗ |
| Aug 21, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 5, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 5, 2026 | 10-Q | 10-Q | ↗ |
| Aug 4, 2026 | 4 | 4 | ↗ |
| Jul 16, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | 10-Q | 10-Q | ↗ |
| May 5, 2026 | 8-K | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 1, 2026 | D | Item 06b | ↗ |
| Apr 24, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 9, 2026 | 8-K | Other Events | ↗ |
| Mar 31, 2026 | 10-K | 10-K | ↗ |
| Feb 12, 2026 | 424B3 | 424B3 | ↗ |
| Feb 9, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Feb 5, 2026 | CORRESP | ↗ | |
| Jan 23, 2026 | S-1 | S-1 | ↗ |
| Jan 13, 2026 | UPLOAD | ↗ | |
| Jan 12, 2026 | DRS | ↗ | |
| Nov 14, 2025 | 10-Q | 10-Q | ↗ |
| Oct 30, 2025 | 8-K | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Oct 27, 2025 | 4 | 4 | ↗ |
| Oct 27, 2025 | SCHEDULE 13D | ↗ | |
| Oct 14, 2025 | D | Item 06b | ↗ |
| Oct 9, 2025 | 4 | 4 | ↗ |
| Oct 9, 2025 | 4 | 4 | ↗ |
| Oct 9, 2025 | 4 | 4 | ↗ |
| Oct 8, 2025 | SCHEDULE 13D | ↗ | |
| Oct 7, 2025 | SCHEDULE 13D | ↗ | |
| Oct 6, 2025 | SCHEDULE 13D/A | ↗ | |
| Oct 6, 2025 | SCHEDULE 13D | ↗ | |
| Oct 6, 2025 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Item 3.03; Change in Control; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.05; Item 5.06; Financial Statements and Exhibits | ↗ |
| Oct 2, 2025 | 4 | ↗ | |
| Aug 29, 2025 | SC 14F1 | SCHEDULE 14F-1 | ↗ |
| Aug 7, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| May 15, 2025 | 10-Q | QUARTERLY REPORT | ↗ |
| Mar 28, 2025 | 10-K | ANNUAL REPORT | ↗ |